ADYX fundamentals

Key facts

—

—

—

—

—

—

—

—

About

Adynxx, Inc. is a clinical stage biopharmaceutical company, which engages in the manufacture, development, and sale of novel, disease-modifying products for the treatment of pain and inflammation. The company was founded by Julien Mamet in 2007 and is headquartered in San Francisco, CA.

Valuation

Fundamental metrics to determine fair value of the stock

Summary

No data available

There's currently no market capitalization, revenue or net income data to show.

Valuation ratios

Growth and Profitability

Company’s recent performance and margins

Dividends

Dividend yield, history and sustainability

No dividends

ADYX has never paid dividends and has no current plans to do so.

Financial health

Financial position and solvency of the company